View in EDS

Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC): Metastatic Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC): Metastatic Non-Small Cell Lung Cancer.
Authors: Antonia, S.J.1, Gettinger, S.2, Goldman, J.3, Chow, L.Q.4, Juergens, R.5, Borghaei, H.6, Brahmer, J.R.7, Shen, Y.8, Harbison, C.8, Chen, A.C.8, Ready, N.E.9, Rizvi, N.A.10
Source: International Journal of Radiation Oncology, Biology, Physics. Nov2014 Supplement, Vol. 90 Issue 5, pS32-S33. 1p.
Subjects: Drug efficacy, Medication safety, Lung cancer treatment, Metastasis, Ipilimumab, Monoclonal antibodies
Database: Engineering Source
FullText Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 98846329
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC): Metastatic Non-Small Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Antonia%2C+S%2EJ%2E%22">Antonia, S.J.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Gettinger%2C+S%2E%22">Gettinger, S.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Goldman%2C+J%2E%22">Goldman, J.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Chow%2C+L%2EQ%2E%22">Chow, L.Q.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Juergens%2C+R%2E%22">Juergens, R.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Borghaei%2C+H%2E%22">Borghaei, H.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Brahmer%2C+J%2ER%2E%22">Brahmer, J.R.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Shen%2C+Y%2E%22">Shen, Y.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Harbison%2C+C%2E%22">Harbison, C.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Chen%2C+A%2EC%2E%22">Chen, A.C.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Ready%2C+N%2EE%2E%22">Ready, N.E.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Rizvi%2C+N%2EA%2E%22">Rizvi, N.A.</searchLink><relatesTo>10</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22International+Journal+of+Radiation+Oncology%2C+Biology%2C+Physics%22">International Journal of Radiation Oncology, Biology, Physics</searchLink>. Nov2014 Supplement, Vol. 90 Issue 5, pS32-S33. 1p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Drug+efficacy%22">Drug efficacy</searchLink><br /><searchLink fieldCode="DE" term="%22Medication+safety%22">Medication safety</searchLink><br /><searchLink fieldCode="DE" term="%22Lung+cancer+treatment%22">Lung cancer treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Metastasis%22">Metastasis</searchLink><br /><searchLink fieldCode="DE" term="%22Ipilimumab%22">Ipilimumab</searchLink><br /><searchLink fieldCode="DE" term="%22Monoclonal+antibodies%22">Monoclonal antibodies</searchLink>
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=98846329
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ijrobp.2014.08.207
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S32
    Subjects:
      – SubjectFull: Drug efficacy
        Type: general
      – SubjectFull: Medication safety
        Type: general
      – SubjectFull: Lung cancer treatment
        Type: general
      – SubjectFull: Metastasis
        Type: general
      – SubjectFull: Ipilimumab
        Type: general
      – SubjectFull: Monoclonal antibodies
        Type: general
    Titles:
      – TitleFull: Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC): Metastatic Non-Small Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Antonia, S.J.
      – PersonEntity:
          Name:
            NameFull: Gettinger, S.
      – PersonEntity:
          Name:
            NameFull: Goldman, J.
      – PersonEntity:
          Name:
            NameFull: Chow, L.Q.
      – PersonEntity:
          Name:
            NameFull: Juergens, R.
      – PersonEntity:
          Name:
            NameFull: Borghaei, H.
      – PersonEntity:
          Name:
            NameFull: Brahmer, J.R.
      – PersonEntity:
          Name:
            NameFull: Shen, Y.
      – PersonEntity:
          Name:
            NameFull: Harbison, C.
      – PersonEntity:
          Name:
            NameFull: Chen, A.C.
      – PersonEntity:
          Name:
            NameFull: Ready, N.E.
      – PersonEntity:
          Name:
            NameFull: Rizvi, N.A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 11
              Text: Nov2014 Supplement
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-print
              Value: 03603016
          Numbering:
            – Type: volume
              Value: 90
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: International Journal of Radiation Oncology, Biology, Physics
              Type: main
ResultId 1